This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barza, M
Right arrow Articles by Gorbach, S L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barza, M
Right arrow Articles by Gorbach, S L

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1979 September; 16(3): 287-292

In vitro activity of LY127935.

M Barza, F P Tally, N V Jacobus and S L Gorbach

ABSTRACT

The activity of LY127935, a beta-lactam antibiotic of novel structure, was studied in vitro against facultative gram-negative bacilli, Staphylococcus aureus, and Bacteroides fragilis. The strains were recent clinical isolates, many of which were relatively resistant to other antibiotics. LY127935 exhibited striking activity against Escherichia coli, Klebsiella pneumoniae, Enterobacter sp., Proteus sp., Serratia marcescens, and B. fragilis with median minimum inhibitory concentrations of less than or equal to 1.0 micrograms/ml. It was somewhat less active against Pseudomonas aeruginosa and S. aureus. Cefotaxime (HR 756) showed very similar activity except that it was substantially weaker against B. fragilis. LY127935 was more active than cefamandole, cefoxitin, or piperacillin; it was also as potent as tobramycin or amikacin against all species except for P. aeruginosa.


Antimicrob Agents Chemother. 1979 September; 16(3): 287-292




This article has been cited by other articles:

  • Fett, D. R., Silverman, C. A., Yoshizumi, M. O. (1984). Moxalactam Retinal Toxicity. Arch Ophthalmol 102: 435-438 [Abstract]  
  • Axelrod, J. L., Kochman, R. S. (1982). Moxalactam Concentration in Human Aqueous Humor After Intravenous Administration. Arch Ophthalmol 100: 1334-1336 [Abstract]  
  • RAHAL, J. J., SIMBERKOFF, M. S. (1982). Host Defense and Antimicrobial Therapy in Adult Gram-Negative Bacillary Meningitis. ANN INTERN MED 96: 468-474 [Abstract]  
  • YU, V. L. (1981). Enterococcal Superinfection and Colonization After Therapy with Moxalactam, a New Broad-Spectrum Antibiotic. ANN INTERN MED 94: 784-785 [Abstract]